Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Historical product/regimen preserved; not a current availability, safety-warning or preferred-antibiotic determination.
Check source scope before reading a dose
GlobalRPh RX List - KETEK
Product / population
Historical oral telithromycin source; product availability and complete serious-safety restrictions require separate verification.
Renal method
CrCl mL/min; coexisting hepatic impairment modifies the renal instruction.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
GlobalRPh-hosted RX List · Historical oral telithromycin source; product availability and complete serious-safety restrictions require separate verification.
Renal method: CrCl mL/min; coexisting hepatic impairment modifies the renal instruction. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
CrCl <30 or dialysis: 600 mg once daily; on hemodialysis days give after the session. If severe renal impairment coexists with hepatic impairment, reduce to 400 mg once daily. CrCl >=30 does not require renal adjustment in this source. Do not interpret these historical renal instructions as confirmation that telithromycin is an appropriate current antibiotic choice.
RDM42-rxlist-telithromycin-54f8da7c8a-C1 · Source locator: Dosage / Renal and hepatic impairment
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.